Literature DB >> 28751772

Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells.

B Yigit1, N Wang1, S-S Chen2, N Chiorazzi2, C Terhorst1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28751772     DOI： 10.1038/leu.2017.241

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Cutting edge commentary: two B-1 or not to be one.

Authors:  Thomas L Rothstein
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 2.  B cells generated by B-1 development can progress to chronic lymphocytic leukemia.

Authors:  Kyoko Hayakawa; Anthony M Formica; Matthew J Colombo; Daiju Ichikawa; Susan A Shinton; Joni Brill-Dashoff; Richard R Hardy
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

3.  The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

Authors:  Yasuhito Hamaguchi; Junji Uchida; Derek W Cain; Guglielmo M Venturi; Jonathan C Poe; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

4.  Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.

Authors:  Shadi Baniasadi; Parivash Eftekhari; Payam Tabarsi; Fanak Fahimi; Mohammad Reza Raoufy; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 2.566

Review 5.  ROS-modulated therapeutic approaches in cancer treatment.

Authors:  Muhammad Hassan Raza; Sami Siraj; Abida Arshad; Usman Waheed; Fahad Aldakheel; Shatha Alduraywish; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-24       Impact factor: 4.553

6.  Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.

Authors:  Regina Jitschin; Andreas D Hofmann; Heiko Bruns; Andreas Giessl; Juliane Bricks; Jana Berger; Domenica Saul; Michael J Eckart; Andreas Mackensen; Dimitrios Mougiakakos
Journal:  Blood       Date:  2014-02-19       Impact factor: 22.113

Review 7.  Hydrogen peroxide as second messenger in lymphocyte activation.

Authors:  Michael Reth
Journal:  Nat Immunol       Date:  2002-12       Impact factor: 25.606

8.  Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Authors:  Shih-Shih Chen; Franak Batliwalla; Nichol E Holodick; Xiao-Jie Yan; Sophia Yancopoulos; Carlo M Croce; Thomas L Rothstein; Nicholas Chiorazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

9.  Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

Authors:  S E M Herman; C U Niemann; M Farooqui; J Jones; R Z Mustafa; A Lipsky; N Saba; S Martyr; S Soto; J Valdez; J A Gyamfi; I Maric; K R Calvo; L B Pedersen; C H Geisler; D Liu; G E Marti; G Aue; A Wiestner
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 11.528

10.  A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells.

Authors:  Burcu Yigit; Peter J Halibozek; Shih-Shih Chen; Michael S O'Keeffe; Jon Arnason; David Avigan; Valter Gattei; Atul Bhan; Osman Cen; Richard Longnecker; Nicholas Chiorazzi; Ninghai Wang; Pablo Engel; Cox Terhorst
Journal:  Oncotarget       Date:  2016-05-03
View more
  2 in total

Review 1.  SLAMF6 in health and disease: Implications for therapeutic targeting.

Authors:  Burcu Yigit; Ninghai Wang; Roland W Herzog; Cox Terhorst
Journal:  Clin Immunol       Date:  2018-10-23       Impact factor: 3.969

Review 2.  Cell toxicity mechanism and biomarker.

Authors:  Yong Zhang
Journal:  Clin Transl Med       Date:  2018-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.